Epidemiology of non-Hodgkin's lymphoma

KC Thandra, A Barsouk, K Saginala, SA Padala… - Medical …, 2021 - mdpi.com
Non-Hodgins's lymphoma (NHL) is the most common hematological malignancy worldwide,
accounting for nearly 3% of cancer diagnoses and deaths. NHL is the seventh most …

Sunlight and Vitamin D: A global perspective for health

M Wacker, MF Holick - Dermato-endocrinology, 2013 - Taylor & Francis
Vitamin D is the sunshine vitamin that has been produced on this earth for more than 500
million years. During exposure to sunlight 7-dehydrocholesterol in the skin absorbs UV B …

ESPEN guidelines on nutrition in cancer patients

J Arends, P Bachmann, V Baracos, N Barthelemy… - Clinical nutrition, 2017 - Elsevier
Cancers are among the leading causes of morbidity and mortality worldwide, and the
number of new cases is expected to rise significantly over the next decades. At the same …

Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity

LH Sehn, RD Gascoyne - Blood, The Journal of the American …, 2015 - ashpublications.org
Although the majority of patients with diffuse large B-cell lymphoma (DLBCL) can be cured
with standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R …

Vitamin D—effects on skeletal and extraskeletal health and the need for supplementation

M Wacker, MF Holick - Nutrients, 2013 - mdpi.com
Vitamin D, the sunshine vitamin, has received a lot of attention recently as a result of a
meteoric rise in the number of publications showing that vitamin D plays a crucial role in a …

Vitamin D insufficiency

TD Thacher, BL Clarke - Mayo Clinic Proceedings, 2011 - Elsevier
Vitamin D deficiency, which classically manifests as bone disease (either rickets or
osteomalacia), is characterized by impaired bone mineralization. More recently, the term …

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy

MJ Maurer, H Ghesquières, JP Jais… - Journal of Clinical …, 2014 - ascopubs.org
Purpose Studies of diffuse large B-cell lymphoma (DLBCL) are typically evaluated by using
a time-to-event approach with relapse, re-treatment, and death commonly used as the …

Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Specialized Program of …

BK Link, MJ Maurer, GS Nowakowski… - Journal of Clinical …, 2013 - ascopubs.org
Purpose This study sought to characterize transformation incidence and outcome for
patients with follicular lymphoma (FL) in a prospective observational series begun after …

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma

MJ Maurer, E Bachy, H Ghesquières… - American journal of …, 2016 - Wiley Online Library
Recent advances in follicular lymphoma (FL) have resulted in prolongation of overall
survival (OS). Here we assessed if early events as defined by event‐free survival (EFS) at 12 …

Vitamin D: update 2013: from rickets prophylaxis to general preventive healthcare

U Gröber, J Spitz, J Reichrath, K Kisters… - Dermato …, 2013 - Taylor & Francis
Vitamin D has received a lot of attention recently as a result of a meteoric rise in the number
of publications showing that vitamin D plays a crucial role in a plethora of physiological …